Medi vs Waystar

Short answer

Waystar is an enterprise healthcare revenue cycle platform built for health systems, hospitals, and large physician groups. It processes over $2.4 trillion in annual gross claims, serves 18 of the 22 institutions on the U.S. News Best Hospitals Honor Roll, and went public on Nasdaq in June 2024 at a $3.5 billion valuation. Its pricing is enterprise-tier — market estimates put typical health system agreements at $200,000 to $1,000,000 or more annually, all custom-quoted with no public tier list.

Medi is a billing-company-first revenue cycle platform priced at a flat $300 per month for the billing company, plus EDI usage billed as it is consumed through Stedi. Providers and client practices are unlimited under that fee.

The honest market-fit answer is that these products serve different buyers. Waystar is the right answer for health systems, hospital networks, and enterprise RCM operations that need a unified platform spanning clinical documentation integrity, prior authorization, denial prevention at scale, patient payment infrastructure, and AI-powered autonomous workflow automation. Medi is the right answer for independent billing companies managing revenue cycle work across multiple client practices, where the billing company is the workspace and the practice is a scoped tenant inside it. Buyers trying to compare them directly are usually asking the wrong question — the more useful question is which product owns the daily work queue for the people doing the billing.

Choose Waystar if your organization looks like a health system

Waystar built its platform for large, complex healthcare organizations. Its current customer base includes more than 30,000 provider organizations and over a million distinct providers, with named clients that include Piedmont, CHRISTUS Health, Cincinnati Children's, Mount Sinai, Renown Health, and University Hospitals. A Black Book survey of 750-plus healthcare leaders rated Waystar 9.75 out of 10 across 18 key performance indicators, ahead of the next competitor at 8.27.

The platform spans six major solution categories: financial clearance (eligibility, prior authorization, patient estimation, charity screening), clinical integrity and revenue capture (charge anomaly detection, DRG validation, clinical documentation improvement via the $1.25 billion Iodine Software acquisition completed in 2025), claim and payer payment management, denial recovery, patient financial care, and analytics and reporting. The AI layer, branded AltitudeAI, runs over 150 trained models and, as of Waystar's Spring 2026 showcase, has prevented $15.5 billion in denials while reducing time spent on denial appeals by 90 percent. A new agentic recoupment-matching solution announced in early 2026 matched $32 million in revenue risk for one early-adopter health system, work the company equated to approximately 13 full-time employees.

Choose Waystar if:

• Your organization is a hospital, health system, integrated delivery network, or large multi-specialty physician group
• You need clinical documentation integrity (CDI) and prebill revenue leakage detection as part of your RCM workflow
• You want a single vendor platform that spans patient access, authorization, claim submission, remittance, denial management, patient payments, and analytics
• Your RCM operation processes claims at a volume where enterprise AI automation — autonomous agents acting on workflow without human intervention — changes the economics meaningfully
• You are already integrated with an EHR such as Epic or Oracle Health and need a clearinghouse and RCM layer that connects to it
• Your budget runs to six-figure annual contracts and your implementation timeline is measured in months, not weeks

Choose Medi if billing is the business you sell

Medi is built for independent billing companies — organizations that run revenue cycle work as their core product and deliver that work across multiple client practices. The platform fee is $300 per month for the billing company. Providers and client practices are unlimited under that fee, so a book that grows from twenty to sixty providers does not change the platform price. Medi does not include an EHR, scheduling, charting, clinical documentation improvement, or patient payment portals, because the buyer is the billing company, not the health system.

Choose Medi if:

• Billing is the business you sell, not a department inside a hospital
• Your team is organized by function — posters, denial leads, follow-up specialists — and needs cross-practice work queues that let a specialist work all their clients' denials without switching contexts
• You want a flat platform fee that does not scale with provider count and does not require a sales call to understand
• Your clients already have an EHR and want a billing-only relationship with your company
• You need practice-scoped permissions so that an offshore poster can access four of your eight clients but not the other four, inside a single workspace
• You want EDI usage billed as it is consumed rather than wrapped into a seat fee you cannot audit

Pricing reality

Waystar does not publish pricing. The company's sales process is demo-first, custom-quote only. Third-party analyses and reviewer aggregators put the range at approximately $11,000 per year on the low end for smaller groups to $200,000 to $1,000,000 or more annually for enterprise health system agreements. Implementation and integration fees are layered on top — estimates run $2,000 to $10,000 for setup, $1,000 to $7,500 or more for EHR integration, and $500 to $5,000 per engagement for training or concierge services.

Medi's fee structure is published and fixed:

The arithmetic for a billing company with fifty providers across eight client practices: the Medi platform is $300 per month, plus EDI usage that typically runs $1,300 to $1,700 per month at normal claim and ERA volumes for a book that size. Total in the range of $1,600 to $2,000 per month. Waystar's custom pricing at that scale is not published, but the structure — enterprise contract, implementation fees, integration costs, and module pricing — is designed for organizations with procurement departments and multi-year budget cycles.

The pricing difference is not a verdict on product quality. It is a structural difference that reflects which buyer each product is designed for. Waystar is pricing a platform that spans CDI, autonomous agents, patient payment infrastructure, and AI models trained on seven billion annual insurance transactions. Medi is pricing a billing-company work surface.

Scale and complexity comparison

Waystar went public on Nasdaq in June 2024 at a $3.5 billion valuation, raising $968 million. The company reported approximately $835 million in 2024 revenue with adjusted EBITDA margins above 40 percent. Its platform processes more than five billion healthcare payment transactions annually. The company's most recent acquisition, Iodine Software for $1.25 billion in 2025, added clinical documentation improvement to a product line that already included Recondo (patient estimation and prior authorization automation, acquired 2019), eSolutions (Medicare-specific RCM analytics, acquired via Francisco Partners), Ovation (AI-powered claims monitoring), and Patientco (patient payments and consumer engagement, acquired 2021). Waystar itself was formed in 2017 through the merger of Navicure and ZirMed, two of the original electronic claims clearinghouse companies.

That acquisition history is relevant context for billing companies evaluating Waystar. The platform is a consolidation of eight-plus previously separate products into a unified revenue cycle suite. The breadth is a genuine competitive advantage for health systems that want a single vendor relationship. For an independent billing company, the breadth introduces a different kind of question: which modules of this enterprise suite will your team actually use, and how does implementation, configuration, and daily operation feel at the scale of fifteen to two hundred providers rather than fifteen hundred?

Medi is built at a different scale by design. The platform manages work at the billing-company level — one workspace, multiple client practices, practice-scoped permissions, cross-practice reporting, and work queue routing that reflects how billing teams are actually organized. There is no clinical documentation improvement, no patient payment portal, no prior authorization workflow, no CDI AI trained on hospital discharge records. Those capabilities are absent because the buyer does not need them, not because the product has not reached them yet.

Stack role

What Waystar covers depends on which modules an organization licenses. At full deployment, the platform covers the complete pre-claim and post-claim revenue cycle: patient identity verification, financial clearance, prior authorization, charge capture integrity, claim scrubbing, submission, remittance processing, denial prevention, appeal generation, patient billing and self-service payments, and analytics across all of those layers. The AltitudeAI agentic layer, announced in January 2026 and expanding through 2026, is designed to move the platform toward autonomous execution — agents that identify a denial reason, pull the relevant clinical record, pre-populate a correction request, and submit an appeal without a staff member doing any of those steps manually.

Waystar also operates as a clearinghouse independently of its full RCM suite. Organizations can use Waystar as a clearinghouse layer — EDI claim submission, 835 remittance, 270/271 eligibility, 276/277 claim status — without licensing the broader platform. The clearinghouse piece is where Waystar's history as the combination of Navicure and ZirMed is most visible; those companies were clearinghouse-first businesses.

Medi covers the billing-company operating layer. Claim building, scrubbing, and submission via Stedi. ERA review with CARC and RARC translation, per-line posting decisions, and PLB segment handling. Denial queues organized by practice and payer. Appeals and appeal tracking. Underpayment detection. Recovery workspace. Payer enrollment. Patient statements. Fee schedule management. Practice and provider setup. Cross-practice A/R aging. Permission tiers for billing-company staff. Audit logging with seven-year retention per HIPAA Security Rule §164.312(b). A BAA is signed before any PHI workflow goes live.

Medi does not include an EHR, scheduling, patient payment portal, prior authorization, CDI, or AI trained on hospital clinical records. If an organization needs those capabilities from its billing software, Medi is the wrong product.

What should a billing company verify before choosing?

The comparison that matters for a billing company is not the marketing positioning of either product. It is the daily work surface your staff will use after implementation. A few questions worth pressure-testing in a side-by-side walkthrough:

• Where does cross-practice denial queue routing live, and can a denial specialist work all of their assigned clients' outstanding denials from a single screen without switching practice contexts?
• How does the system handle a payer ERA that includes PLB segments, recoupment lines, and line-level adjustments for claims across multiple client practices at once?
• What does a billing-company manager see when they want A/R aging across the full book versus one client, and can they drill from the aggregate view to the individual claim?
• How do practice-level billing rules layer on top of payer-level rules without creating conflicts a biller has to manually resolve?
• What does the permission model look like for a billing company with offshore staff who should access some but not all client practices?
• How is payer enrollment — trading partner agreements, NPI registration, ERA enrollment — organized and tracked across multiple client practices in the system?
• What does the all-in first-year cost look like, including implementation, integration, training, and any module or usage fees that are not in the base contract?
• What data can be exported before any migration decision, and what operational state — open appeals, in-flight authorizations, unposted ERAs, follow-up notes — cannot be exported cleanly?

For a billing company evaluating Waystar, the critical question is whether Waystar's enterprise platform is being considered because it genuinely fits the operational need, or because the billing company's largest client is a health system that already uses Waystar and the billing company is being pulled into the same procurement.

Is Medi always a better fit than Waystar?

No. The honest answer depends on what kind of organization is doing the evaluating.

Waystar is the right answer for hospital systems and enterprise RCM operations. Its scale, AI infrastructure, CDI capabilities, payer network breadth, and integrated patient payment tools are designed for organizations that process hundreds of thousands of claims a year and want a single vendor relationship that spans the full revenue cycle. Hospitals on Waystar are not buying the wrong product. They are buying the right product for their context.

Medi is the right answer for independent billing companies whose clients do not need a CDI platform, patient financial engagement tools, or enterprise AI agents, and who want a billing-company work surface with a flat, predictable fee. The billing company that is primarily managing claims, denials, appeals, ERAs, and collections across a portfolio of small to mid-sized practices is a different buyer than a hospital CFO evaluating an enterprise contract.

Where the comparison genuinely comes up is when an independent billing company has grown large enough to attract Waystar's attention, or when a Waystar-using hospital system's billing office is wondering whether its in-house billing team should be on the same platform as the hospital's clinical departments. Those are legitimate evaluation questions, and the answer depends on which workflows are actually driving the daily work and who owns them.

Other comparisons billing companies look at

Waystar competes at enterprise scale with athenahealth, Epic Resolute, and other large RCM platforms. For independent billing companies, the more relevant comparisons are mid-market PM and billing-company-first platforms.

• Medi vs Tebra — most common comparison for independent billing companies; very different scale than Waystar.
• Medi vs AdvancedMD — per-provider PM that moved its clearinghouse to Waystar in 2025.
• Medi vs CollaborateMD — direct billing-company-first PM at independent scale.
• Medi vs PracticeSuite — multi-tenant billing-service PM with EHR bundling.
• Medi vs Claim.MD — clearinghouse-focused at the opposite end of the scale from Waystar.
• Medi vs Office Ally — free-tier clearinghouse with Practice Mate PM.
• Medi vs Availity — payer-network layer that competes with Waystar at the enterprise clearinghouse tier.

The billing-company software evaluation guide covers the question of when enterprise RCM is the right answer versus a billing-company-first operating layer.

Frequently asked questions

Is Waystar a clearinghouse or a full RCM platform?

Both, depending on how it is licensed. Waystar began as the combination of Navicure and ZirMed, two established electronic claims clearinghouses. The company has since acquired and built a full revenue cycle management platform on top of that clearinghouse foundation, adding prior authorization, CDI, patient payments, denial management, and AI-powered workflow automation. Organizations can license Waystar as a clearinghouse layer without the full platform, or as a full end-to-end RCM solution. The clearinghouse history is why Waystar has over 850 payer connections and why EHR vendors like NextGen Healthcare have published integrations with Waystar specifically for EDI.

Why is Waystar rarely the right fit for independent billing companies?

The product is engineered at health-system scale and health-system economics. Enterprise contracts, custom pricing, implementation timelines measured in months, and a platform breadth that includes CDI, patient payment portals, and agentic AI automation are well-matched to the complexity of a hospital billing department. For an independent billing company managing fifteen to two hundred providers across multiple client practices, that breadth introduces overhead — configuration complexity, implementation cost, and a product surface that addresses clinical and patient-facing workflows the billing company does not own. The billing company's daily work — claim building, denial routing, ERA posting, follow-up queues, payer enrollment — is a subset of what Waystar covers, and a smaller, billing-company-first platform may fit that subset more directly.

What does Waystar actually cost?

Waystar does not publish pricing. All quotes require a sales engagement. Third-party aggregators and reviewer platforms cite a range starting at roughly $11,000 per year for smaller organizations, with enterprise health system agreements commonly falling in the $200,000 to $1,000,000 or more per year range. Implementation fees, EHR integration fees, and training or concierge engagements are layered on top and are also custom-quoted. The pricing structure is designed for organizations with formal procurement processes, multi-year budget cycles, and dedicated IT teams to manage integration.

Does Medi connect to the same payers as Waystar?

Medi uses Stedi as its clearinghouse for 837 claim submission, 835 ERA, 270/271 eligibility, 276/277 claim status, 278 authorization, and 277CA acknowledgment. Stedi's payer network covers the same major commercial payers, Medicare, and Medicaid programs that most billing companies work with. Waystar has documented connections to over 850 payers. For specialty payers or Medicaid state programs with non-standard EDI requirements, payer connectivity is worth verifying directly with either vendor.

Can a billing company use both Waystar and Medi?

In theory, yes, though it is unusual in practice. Some billing companies that serve large health systems use Waystar at the health system level for enterprise RCM and CDI, while using a billing-company-first platform like Medi for their independent practice clients. The operational complexity of running two platforms — enrollment, work queues, reporting, permissioning — is real, and most billing companies choose one operating layer. The more common scenario is that a billing company evaluating Waystar is doing so because a large health system client uses Waystar and the billing company is being asked to connect into it, not replace its own platform with it.

How current is this comparison?

Last reviewed 2026-05-17. Waystar is a publicly traded company (Nasdaq: WAY) and its product, pricing, and acquisitions change. The primary sources for current Waystar positioning are waystar.com and investors.waystar.com. Pricing estimates cited above come from third-party reviewer aggregators and market analyses available at the time of review; they are estimates, not published rates. Verify current pricing and packaging directly with Waystar before making any procurement decision.